-
Rodman & Renshaw Raises 2012 Production Forecast for Voyager Oil & Gas
Tuesday, January 31, 2012 - 9:25am | 116According to a research report released today, Rodman & Renshaw are increasing 2012 forecast for Voyager Oil & Gas Inc. (NYSE: VOG) based on production trending above expectations. “Production appears to be trending above our expectations, as VOG exited the year at >1.0 MBoe/d (vs. our...
-
UPDATE: Rodman & Renshaw Raises Magnum Hunter's PT to $8
Tuesday, January 31, 2012 - 9:25am | 113In a recent research report, Rodman & Renshaw increased Magnum Hunter Resources Corp.'s (NYSE: MHR) PT from $7.50 to $8 due to production trending above expectations. According to Rodman & Renshaw, “Higher EURs in the Marcellus cause our target to rise $0.50 to $8.00, and additional upside...
-
Rodman & Renshaw Reiterates Market Outperform on Dell
Friday, August 12, 2011 - 9:27am | 56Rodman & Renshaw reiterated its Market Outperform rating on Dell (NASDAQ: DELL). At the same time, the rating agency has a price target of $18 placed on the company's stock. On Thursday, DELL closed the day at $14.72. Its shares added 0.48% to their value in today's pre-market trading to stand...
-
Rodman & Renshaw Reiterates Market Outperform and PT of $5.50 on U.S. Energy
Friday, August 12, 2011 - 9:23am | 45Rodman & Renshaw reiterated its Market Outperform rating on U.S. Energy (NASDAQ: USEG). At the same time, the rating agency left its price target on the company's stock unchanged at $5.50. On Thursday, USEG closed the day at $3.12.
-
UPDATE: Rodman & Renshaw Reiterates Market Outperform on Crimson Exploration, Reduces PT to $5.25
Friday, August 12, 2011 - 9:07am | 36Rodman & Renshaw reiterated its Market Outperform rating on Crimson Exploration (NASDAQ: CXPO). At the same time, the rating agency reduced its price target on the company's stock from $5.50 to $5.25. On Thursday, CXPO closed the day at $2.80.
-
Rodman & Renshaw Reiterates Market Outperform and PT of $10 on SciClone Pharmaceuticals
Friday, August 12, 2011 - 9:04am | 44Rodman & Renshaw reiterated its Market Outperform rating on SciClone Pharmaceuticals (NASDAQ: SCLN). At the same time, the rating agency left its price target on the company's stock unchanged at $10. On Thursday, SCLN closed the day at $5.07.
-
Rodman & Renshaw Initiates Coverage on Harvest Natural Resources with Market Outperform and PT of $20
Friday, August 12, 2011 - 8:15am | 41Rodman & Renshaw initiated its coverage on Harvest Natural Resources (NYSE: HNR) with a Market Outperform rating and a price target of $20. On Thursday, HNR added 4.74% to its value to end the day at $9.50.
-
Rodman & Renshaw Downgrades China North East Petroleum Holdings to Market Perform
Friday, August 12, 2011 - 6:17am | 38Rodman & Renshaw downgraded its rating on China North East Petroleum (NYSE: NEP) from Market Outperform to Market Perform. On Thursday, NEP lost 3.27% of its value to finish the day at $2.37.
-
Rodman & Renshaw Initiates Coverage of Top Image Systems with Market Outperform and PT of $4
Friday, August 12, 2011 - 3:43am | 41Rodman & Renshaw initiated its coverage of Top Image Systems (NASDAQ: TISA) with a Market Outperform rating and a price target of $4. On Thursday, TISA added 5.31% to its value to finish the day at $2.38.
-
Rodman & Renshaw Reiterates Market Outperform and PT of $38 on Energy XXI
Friday, August 12, 2011 - 3:40am | 49Rodman & Renshaw reiterated its Market Outperform rating on Energy XXI (NASDAQ: EXXI). At the same time, the rating agency left its price target on the company's stock unchanged at $38. On Thursday, EXXI added 8.53% to its value to finish the day at $25.07.
-
Rodman & Renshaw Reiterates Market Outperform and PT of C$2.82 on Eastmain Resources
Friday, August 12, 2011 - 3:34am | 43Rodman & Renshaw reiterated its Market Outperform rating on Eastmain Resources (TSE: ER). At the same time, the rating agency left its price target on the company's stock unchanged at VC$2.82. On Thursday, ER added 4.27% to its value to finish the day at C$1.22.
-
Rodman & Renshaw Reiterates Market Outperform on Winner Medical Group, New PT at $8
Friday, August 12, 2011 - 3:31am | 49Rodman & Renshaw reiterated its Market Outperform rating on Winner Medical Group (NASDAQ: WWIN). At the same time, the rating agency modified its price target on the company's stock to $8. On Thursday, WWIN lost 0.48% of its value to finish the day at $4.18.
-
Rodman & Renshaw Reiterates Market Outperform and PT of $5.25 on Voyager Oil & Gas
Thursday, August 11, 2011 - 9:27am | 37Rodman & Renshaw reiterated its Market Outperform rating on Voyager Oil & Gas (NYSE: VOG). At the same time, the rating agency left its price target on the company's stock unchanged at $5.25. On Wednesday, VOG closed the day at $2.48.
-
UPDATE: Rodman & Renshaw Reiterates Market Outperform on Adventrx Pharmaceuticals, Slashes PT to $9
Thursday, August 11, 2011 - 7:43am | 66Rodman & Renshaw reiterated its Market Outperform rating on Adventrx Pharmaceuticals (NYSE: ANX). At the same time, the rating agency reduced its price target on the company's stock from $16 to $9. On Wednesday, ANX had a disastrous session, losing 58.28% of its value to end the day at $1.06....
-
Rodman & Renshaw Downgrades China Information Technology to Market Perform
Thursday, August 11, 2011 - 3:00am | 37Rodman & Renshaw downgraded its rating on China Information Technology (NASDAQ: CNIT) from Market Outperform to Market Perform. On Wednesday, CNIT lost 23.34% of its value to finish the day at $1.42.